Patents
Patents for C07H 11 - Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof (1,722)
11/2008
11/18/2008CA2301725C Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses
11/12/2008EP1095158B1 Process and materials for production of glucosamine
11/12/2008EP0870771B1 Sugar compounds
11/05/2008CN100430408C Continuous process for the preparation of fructopyranose sulfamate derivatives
10/2008
10/30/2008US20080269478 Method for synthesizing sucrose-6-acetic ester
10/29/2008EP1985299A1 Therapeutic agent for traumatic neuropathy and/or movement disorder
10/08/2008CN101282984A Immunogens for meningitidis-a vaccines
10/08/2008CN101279991A Iota-carrageenan even oligosacchride alcohol monomer and preparation thereof
10/08/2008CN101279990A Iota-carrageenan even oligosacchride monomer and preparation thereof
09/2008
09/18/2008WO2007140022A3 Fucoidan compositions and methods
09/12/2008WO2008011588A3 Glycoconjugates of phosphoramidate alkylators for treatment of cancer
09/10/2008EP1967203A1 Polysaccharide vaccine for staphylococcal infections
09/04/2008US20080214802 Treating sepsis, septicemia and septic shock
08/2008
08/19/2008US7414126 Process for the preparation of topiramate
08/05/2008CA2223140C Substituted liposaccharides useful in the treatment and prevention of endotoxemia
07/2008
07/31/2008WO2008090631A1 Fucoidan-derived oligosaccharide
07/24/2008US20080176818 Sulfoglycolipid Antigens, Their Extraction From Mycobacterium Tuberculosis, and Their Use Against Tuberculosis
07/08/2008CA2218884C Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof
06/2008
06/26/2008CA2662506A1 Glms riboswitches, structure-based compound design with glms riboswitches, and methods and compositions for use of and with glms riboswitches
06/18/2008CN100395252C Method for continuous separation of fructose-1,6-diphosphate
06/17/2008CA2253113C Carbohydrate derivatives
06/03/2008US7381820 α-1-phosphorylated-2-deoxy-2-fluoroarabinoside and process for producing 2′-deoxy-2′-fluoro-β-d-arabinonucleoside
05/2008
05/29/2008WO2008041131A3 Anticoagulant compounds
05/29/2008WO2008010231A3 A process for the purification of topiramate
05/28/2008EP1178051B1 Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside
05/22/2008US20080119415 Therapy and prophylaxis of infectious disease, autoimmune disease or allergic condition by administering monophosphoryl lipid a (mpl) and a l-seryl aminoalkyl glucosaminide phosphate compound (agp)
05/22/2008CA2669401A1 Functionalized beta 1,6 glucosamine disaccharides and process for their preparation
05/22/2008CA2669230A1 Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
05/21/2008EP1284740B1 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with monosaccharide-based compounds
05/21/2008EP1096952B1 Polysaccharide vaccine for staphylococcal infections
05/20/2008US7375095 Sugar derivative
04/2008
04/29/2008US7365191 immunology; antitumor agents; viricides; anticancer agents; antiinflammatory agents; oligosaccharde containing glucose, galactose, mannose
04/23/2008CN100383154C Gemini boric acid ester glucose acylamine compound, and its preparing method and use
04/10/2008WO2008041131A2 Anticoagulant compounds
04/10/2008CA2665392A1 Anticoagulant compounds
04/09/2008EP1908768A1 Anticoagulant compounds
04/01/2008US7351695 Topiramate sodium, topiramate lithium, topiramate potassium, or polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, and amorphous forms; seizures, obesity, neuropathic pain, affective disorders, tobacco cessation, chronic fatigue syndrome, drug addiction; highly soluble, bioavailability
03/2008
03/05/2008EP1409501B1 Inositol phosphoglycan derivatives and their medical uses
02/2008
02/27/2008EP1418950B1 Solid-phase nucleophilic fluorination
02/26/2008US7335500 Generating preferential fucose compound; obtain sample, incubate with fucosyltransferae, recover fucosylated compound
02/20/2008EP1421091A4 Saccharide sulfation methods
02/19/2008US7332480 Compositions for the regulation of cytokine activity
02/13/2008EP1885734A2 Immunogens for meningitidis-a vaccines
02/13/2008EP1417223B8 Process for preparing lipid ii
01/2008
01/23/2008CN100363373C Preparation method of isomalto loigosaccharide sulphate (IMOS)
01/02/2008CN100358910C Glucose phosphonic amide crystals and preparation process and use thereof
12/2007
12/26/2007EP1870468A2 LPS with reduced toxicity from genetically modified gram negative bacteria
12/20/2007US20070293442 Antithrombotic compound
12/06/2007CA2689445A1 Fucoidan compositions and methods
11/2007
11/29/2007US20070275910 Phosphoramidate Derivatives
11/29/2007US20070274911 Production of 2-18F-2-Deoxy-D-Glucose Via Solid-Phase Synthesis
11/28/2007CN101080234A Certain aminoalkyl glucosaminide phosphate compounds and their use
11/22/2007WO2007132537A1 Novel k04-0144 substances and process for production thereof
11/20/2007CA2171743C Nucleotide analogs
11/15/2007US20070265334 Method for treating amyloidosis
11/14/2007EP1480654A4 Carbohydrate-based anti-wrinkle and tissue remodelling compounds
10/2007
10/16/2007CA2289585C Novel imaging agents and methods for the preparation and use thereof
10/16/2007CA2205135C Novel 1,2-dioxetane compounds with haloalkoxy groups, methods of preparation and use
09/2007
09/27/2007US20070225254 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide- based compounds
09/26/2007EP1417223B1 Process for preparing lipid ii
09/19/2007EP1127137B1 Lps with reduced toxicity from genetically modified gram negative bacteria
09/18/2007CA2167361C 2,2-difluoro-3-carbamoyl ribose sulfonate compounds and process for the preparation of beta nucleosides
09/13/2007US20070212763 Process For Producing Pentose-5-Phosphate Ester
08/2007
08/30/2007WO2007096532A1 Mannosyl-1 phosphates, preparation method and therapeutic use, in particular against the cdg-ia syndrome
08/30/2007CA2642843A1 Mannosyl-1 phosphates, preparation method and therapeutic use, in particular against the cdg-ia syndrome
08/28/2007CA2222103C Inositolglycans having insulin-like action
08/09/2007US20070185037 Sulfated oligosaccharide derivatives
08/08/2007CN101012249A K-carrageenin even number oligosaccharide alcohol monomer and preparing method thereof
08/02/2007US20070178487 Active-site engineering of nucleotidylyltransferases and general enzymatic methods for the synthesis of natural and "unnatural" udp- and tdp-nucleotide sugars
08/01/2007CN101010328A Certain aminoalkyl glucosaminide phosphate compounds and their use
08/01/2007CN101007829A 1,6-diphospho-D-fructose ester arginine salt and its pharmaceutical uses
07/2007
07/26/2007WO2007083634A1 Therapeutic agent for traumatic neuropathy and/or movement disorder
07/12/2007WO2006120576A3 Immunogens for meningitidis-a vaccines
07/04/2007CN1990495A Method for quantitatively determining specific groups constituting heparins
06/2007
06/27/2007CN1989146A Sulfated oligosaccharide derivatives
06/21/2007WO2007069603A1 Physiologically active glycolipid
06/20/2007CN1322000C Diabetin-1, 6-diphosphonie acid as well as preparation method and application
06/19/2007US7232900 making a glycosyl halide comprising reacting an O-silyl glycoside with an alpha , alpha -dihalomethyl alkyl ether in the presence of zinc chloride, zinc bromide or boron trifluoride; intermediate to synthesis of the immunostimulants
06/14/2007US20070135627 Hydrolysis, phosphorylation and removing protective groups; purine nucleoside phosphorylase, hydrolase
05/2007
05/31/2007WO2007060692A2 Compositions for increasing bioavailability of peptides or proteins and method thereof
05/24/2007US20070117971 Cellulose based optical film material and method for forming the same
05/23/2007CN1966512A Dwarf lilyturf polysaccharide MDG-1 sulfated derivative, its preparation method and uses
05/23/2007CN1317287C Oligose polysulfate and preparation process thereof
05/10/2007WO2007052308A2 Glyco-phosphorylated biologically active agents
05/02/2007EP1414824B1 Novel anticonvulsant derivative salts
05/01/2007US7211663 Antiinflammatory agents; immobilized on solid support
04/2007
04/25/2007EP1776375A2 Certain aminoalkyl glucosaminide phosphate compounds and their use
04/18/2007EP1775303A1 Topiramate and pharmaceutical compositions thereof
04/12/2007US20070082850 Derivatives of mannose-6-phosphate that are resistant to phosphatase and mannosidase enzymes; for treatment of disease or condition wherein T lymphocyte migration from blood to tissue or other extravascular site is step in development of the disease or condition; 1-methyl-2,3,4,6-tetrabenzyl-mannoside
03/2007
03/27/2007US7196209 Continuous process for the preparation of fructopyranose sulfamate derivatives
03/14/2007CN1930182A Antithrombotic compound
03/14/2007CN1304008C Medical compsns.
03/08/2007CA2620027A1 Process for production of lipid a analogue
03/07/2007EP1758596A2 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
02/2007
02/28/2007EP1119577B1 Synthesis of oligonucleotides, reagents and methods related thereto
02/22/2007US20070042370 Fluorescent substrates for detecting organophosphatase enzyme activity
02/20/2007CA2218872C Preparation and use of sulfated oligosaccharides
02/01/2007WO2007013609A1 Fucoidan-derived oligosaccharide
01/2007
01/31/2007CN1906203A Glycosaminoglycan (GAG) mimetics
01/04/2007WO2004062599A3 Certain aminoalkyl glucosaminide phosphate compounds and their use
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 18